Deepak Fertilisers And Petrochemicals (DEEPAKFERT) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
13 Nov, 2025Executive summary
Q2 FY26 consolidated revenue grew 9% YoY to ₹3,006 Cr, with PAT flat at ₹214 Cr; H1 FY26 revenue rose 13% YoY to ₹5,665 Cr and PAT increased 11% to ₹458 Cr.
Mining Chemicals (TAN) and Crop Nutrition businesses outperformed, while Ammonia and IPA segments faced headwinds from global volatility.
Specialty products now make up 28% of Crop Nutrition revenue, with Croptek volumes up 54% YoY.
Strategic acquisition of Platinum Blasting Services in Australia completed, strengthening mining solutions and forward integration.
Strategic capex projects and transition from commodity to specialty products are progressing, supporting future growth.
Financial highlights
Q2 FY26 operating revenue: ₹3,006 Cr (up 9% YoY); H1 FY26: ₹5,665 Cr (up 13% YoY).
Q2 FY26 EBITDA: ₹464 Cr (down 6% YoY); H1 FY26: ₹977 Cr (up 2% YoY); Q2 EBITDA margin declined to 15% from 18% YoY.
Q2 FY26 PAT: ₹214 Cr (flat YoY); H1 FY26 PAT: ₹458 Cr (up 11% YoY); PAT margin for Q2 at 7.1%.
Net debt increased by ₹97 Cr in H1 FY26 despite ₹870 Cr capex; net debt/EBITDA at 1.74x, net debt/equity at 0.48x as of Sep 2025.
Five-year revenue CAGR at 15%, EBITDA CAGR at 19%, and PAT CAGR at 23%.
Outlook and guidance
Robust Rabi season demand expected for crop nutrition due to favorable monsoon and reservoir levels.
TAN and Nitric Acid projects on track for commissioning by end of FY26; capacity utilization expected at 70% in FY27 and 80%+ in FY28.
New LNG contract from May 2026 anticipated to reduce gas costs and improve ammonia margins.
Margins expected to return to 18%-20% for FY26; FY27 seen as a stepping stone year with new capacities.
IPA and Ammonia segments anticipate near-term recovery as prices stabilize and operational efficiencies improve.
Latest events from Deepak Fertilisers And Petrochemicals
- EBITDA margin hit 20.4% and net profit rose 76% YoY on strong segment growth and restructuring.DEEPAKFERT
Q1 20252 Feb 2026 - Revenue up 10% but margins fell; CapEx, LNG contract, and specialty focus to drive future growth.DEEPAKFERT
Q3 25/262 Feb 2026 - Q2 FY25 delivered strong profit growth, margin expansion, and strategic progress on CAPEX and restructuring.DEEPAKFERT
Q2 24/2517 Jan 2026 - Q3FY25 revenue up 39% YoY, net profit up 318%, with strong margins and segment growth.DEEPAKFERT
Q3 24/259 Jan 2026 - FY25 net profit doubled on 18% revenue growth, specialty share rose, and dividend declared.DEEPAKFERT
Q4 24/2521 Nov 2025 - Q1 FY26 delivered double-digit revenue and profit growth, with specialty and crop nutrition leading.DEEPAKFERT
Q1 25/2616 Nov 2025